P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction
Luiz Eduardo Baggio Savio1,2, Mariana G Juste Andrade1, Paola de Andrade Mello2,3
1Laboratory of Immunophysiology, Biophysics Institute Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Molecular Neurobiology
|October 13, 2016
Summary
Targeting the P2X7 receptor may reduce brain damage during sepsis. Blocking this receptor decreases inflammation and oxidative stress, offering a potential therapeutic strategy for sepsis-associated encephalopathy.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Sepsis causes widespread inflammation and organ failure, including brain dysfunction (sepsis-associated encephalopathy).
- Extracellular nucleotides, cytokines, and oxidative stress are implicated in sepsis-associated encephalopathy's pathophysiology.
- P2X7 receptor activation by ATP drives IL-1β release and reactive oxygen species production.
Purpose of the Study:
- To investigate the role of the P2X7 receptor in purinergic signaling during sepsis.
- To determine the regulatory role of the ectonucleotidase CD39 in P2X7-mediated responses.
- To explore the ATP-P2X7-STAT3 signaling axis in sepsis-associated encephalopathy.
Main Methods:
- Used a cecal ligation and puncture (CLP) model of sepsis in wild type, P2X7 receptor-deficient, and CD39-deficient mice.
- Assessed markers of oxidative stress and cytokine production (IL-1β, IL-6) in murine brains.
- Investigated STAT3 activation in the cerebral cortex and hippocampus.
Main Results:
- Genetic deletion of P2X7 receptor reduced brain oxidative stress markers 24 hours post-sepsis.
- P2X7 receptor inhibition or ablation attenuated IL-1β and IL-6 production in septic mouse brains.
- CD39 deficiency exacerbated IL-1β levels in septic brains, indicating CD39's protective role.
- P2X7 receptor blockade decreased STAT3 activation in septic mouse brains.
Conclusions:
- The P2X7 receptor plays a significant role in sepsis-induced brain inflammation and oxidative stress.
- CD39 acts as a negative regulator of P2X7 receptor-mediated inflammatory responses.
- The ATP-P2X7-STAT3 signaling pathway is involved in sepsis-associated encephalopathy.
- P2X7 receptor blockade is a potential therapeutic target for mitigating sepsis-related brain injury.
